Shares of Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) shot up 3.3% during mid-day trading on Friday. The company traded as high as $4.3550 and last traded at $4.32. 1,787,746 shares changed hands during trading, an increase of 429% from the average daily volume of 337,931 shares. The stock had previously closed at $4.18.
Silverback Therapeutics Trading Down 6.7%
The firm has a market cap of $145.31 million, a price-to-earnings ratio of -1.67 and a beta of 0.60. The firm has a 50-day moving average of $4.84 and a two-hundred day moving average of $6.86.
Silverback Therapeutics Company Profile
Silverback Therapeutics was a clinical-stage biopharmaceutical company focused on developing medicines that modulate the immune system within specific tissues. Its approach was designed to combine the targeting capabilities of monoclonal antibodies with biologically active payloads, with the goal of directing immune activity to diseased tissue while limiting effects elsewhere in the body.
The company’s ImmunoTAC platform supported the development of antibody-based drug candidates for oncology and other serious diseases.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
